Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL823104 | 1.00 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL14069341 | 1.00 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL29823542 | 1.00 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL1706160 | 1.00 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL13823271 | 1.00 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL29823181 | 0.89 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL29823844 | 0.89 | KDM4E (0.41) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL823105 | 0.82 | ALOX5 (0.40) | ALOX5 | |
| SCHEMBL12241230 | 0.81 | KDM4E (0.33) | KDM4EMEN1AKR1B10ALOX5KMT2A | |
| SCHEMBL20725736 | 0.81 | KDM4E (0.33) | KDM4EMEN1AKR1B10ALOX5KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210346385-A1 | TASTE-MASKED DOSAGE FORMS | DEEP OCEAN CAPITAL MANAGEMENT LP | 2021-11-11 | — | — | US | disclosed |
| EP-1481671-B9 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM | KIRIN BREWERY (JP) | 2014-02-19 | — | — | EP | disclosed |
| EP-1481671-B1 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM | KIRIN BREWERY (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20100080862-A1 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM | KIRIN BEER KABUSHIKI KAISHA | 2010-04-01 | — | — | US | disclosed |
| US-20060233902-A1 | Compositions and foods for improving lipid metabolism | KIRIN BEER KABUSHIKI KAISHA (JP) | 2006-10-19 | — | — | US | disclosed |
| EP-1481671-A1 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM | KIRIN BEER KABUSHIKI KAISHA (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100080862-A1 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM | PPARG, PPARA, PPARD | KDM4E 4373/4885MEN1 4726/4885AKR1B10 1664/4885 |
| US-20060233902-A1 | Compositions and foods for improving lipid metabolism | PPARG, PPARA, PPARD | KDM4E 4373/4885MEN1 4726/4885AKR1B10 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.